Takahiro Okamoto - Concepedia

Author

Takahiro Okamoto

Tokyo Women's Medical University ORCID

Also Known As

Okamoto Takahiro, T Okamoto, T. Okamoto, T. Tibi, TAKAHIRO OKAMOTO, Taiki Okamoto, Takahiro OKAMOTO, Takahiro Okamoto

297

Publications

5.7K

Citations

H-Index

154

Concepts

All Affiliations

Tokyo Women's Medical University Hyogo Medical University Kindai University Kyoto University Sapporo Medical University

About

Takahiro Okamoto is an author at Tokyo Women's Medical University specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	58	2.6K
2	Health Sciences	13	15	638
3	Engineering	3	3	128
4	Allergy	2	2	58
5	Nursing	1	1	11

Takahiro Okamoto

108

Publications

Citations

H-Index

Page 1

	Year	Citations
Prognostic Factors and Treatment Outcomes for Anaplastic Thyroid Carcinoma: ATC Research Consortium of Japan Cohort Study of 677 Patients Iwao Sugitani, Akira Miyauchi, Kiminori Sugino, World Journal of Surgery	2012	261
Therapeutic Strategy for Differentiated Thyroid Carcinoma in Japan Based on a Newly Established Guideline Managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons Hiroshi Takami, Yasuhiro Ito, Takahiro Okamoto, World Journal of Surgery	2010	213
The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer Yasuhiro Ito, Naoyoshi Onoda, Takahiro Okamoto Endocrine Journal Thyroid TumorsSurgical OncologyEndocrine OncologyMedicineSurgical Pathology	2020	189
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study Jin Takeuchi, Taiichi Kyo, K Naito, Leukemia Hematological MalignancyLymphoid NeoplasiaIntensive ConsolidationOncologyHealth Sciences	2002	188
Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Dave S.�B. Hoon, Peter J. Bostick, Calvin Kuo, PubMed Molecular MarkersPathologyCancer RegistrationDermatologyMelanoma Cells	2000	148
Rb Regulates DNA Damage Response and Cellular Senescence through E2F-Dependent Suppression of N-Ras Isoprenylation Awad Shamma, Yujiro Takegami, Takao Miki, Cancer Cell ChromatinGenome InstabilityDna DamageCell RegulationE2f-dependent Suppression	2009	135
Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up Wenwu Dong, Kiyomi Horiuchi, Hiroki Tokumitsu, Thyroid	2019	118
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment Masaya Okada, Jun Imagawa, Hideo Tanaka, Clinical Lymphoma Myeloma & Leukemia	2018	116
Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database Akihiro Sakurai, Shinichi Suzuki, Shinji Kosugi, Clinical Endocrinology	2011	115
Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome Hiroyuki Takatsuka, Y Takemoto, Shinji Yamada, Bone Marrow Transplantation InflammationTransplantationMarrow TransplantationAutoimmune DiseaseBone Marrow Failure	2000	109

Page 1